Cutler Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,000
| Closed | -$1K | – | 1059 |
|
|
2023
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1217 |
|
|
2023
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1297 |
|
|
2023
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1279 |
|
|
2023
Q1 | $1K | Sell |
1,000
-200
| -17% | -$200 | ﹤0.01% | 1308 |
|
|
2022
Q4 | $1K | Hold |
1,200
| – | – | ﹤0.01% | 1614 |
|
|
2022
Q3 | $1K | Hold |
1,200
| – | – | ﹤0.01% | 1796 |
|
|
2022
Q2 | $2K | Hold |
1,200
| – | – | ﹤0.01% | 1704 |
|
|
2022
Q1 | $3K | Hold |
1,200
| – | – | ﹤0.01% | 1748 |
|
|
2021
Q4 | $5K | Hold |
1,200
| – | – | ﹤0.01% | 1801 |
|
|
2021
Q3 | $6K | Hold |
1,200
| – | – | ﹤0.01% | 1812 |
|
|
2021
Q2 | $7K | Buy |
1,200
+700
| +140% | +$4.08K | ﹤0.01% | 1789 |
|
|
2021
Q1 | $3K | Hold |
500
| – | – | ﹤0.01% | 1836 |
|
|
2020
Q4 | $3K | Sell |
500
-600
| -55% | -$3.6K | ﹤0.01% | 1617 |
|
|
2020
Q3 | $7K | Buy |
1,100
+900
| +450% | +$5.73K | ﹤0.01% | 1377 |
|
|
2020
Q2 | $1K | Sell |
200
-100
| -33% | -$500 | ﹤0.01% | 1448 |
|
|
2020
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 1293 |
|
|
2019
Q4 | $2K | Hold |
300
| – | – | ﹤0.01% | 1387 |
|
|
2019
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 1359 |
|
|
2019
Q2 | $3K | Sell |
300
-700
| -70% | -$7K | ﹤0.01% | 1420 |
|
|
2019
Q1 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 1192 |
|
|
2018
Q4 | $15K | Buy |
+1,000
| New | +$15K | ﹤0.01% | 1165 |
|
|
2018
Q3 | – | Sell |
-100
| Closed | -$2K | – | 1714 |
|
|
2018
Q2 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 1536 |
|
|
2018
Q1 | – | Sell |
-500
| Closed | -$10K | – | 1913 |
|
|
2017
Q4 | $10K | Buy |
+500
| New | +$10K | ﹤0.01% | 1603 |
|